ImpactOrtho, Inc.
$52.7K 839 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
On Target Laboratories, Inc
On Target Laboratories, Inc reported $52,963.40 across General Payments, Research, and Ownership to 114 physicians and teaching hospitals across 114 transactions.
- $53.0K Below-median payer
- All-tracks total
- 114 Below-median volume
- Transactions
- 114 Below-median reach
- Recipients
- #1336
- of 1,925 companies
On Target Laboratories, Inc reported $52,963.40 across all CMS Open Payments tracks (General + Research + Ownership) to 114 physicians and teaching hospitals in Program Year 2024 - ranking #1336 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $52,963.40, averaging $464.59 per recipient.
On Target Laboratories, Inc's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
24/100
Total payments
F
10/100
Transaction volume
F
11/100
Physician reach
F
11/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer on-target-laboratories-inc On Target Laboratories, Inc
$53.0K · #1336/1,925 · 0.0% industry · PY2024
- TOT $53.0K
- RANK #1336
- SHARE 0.0%
- TXN 114
- RCP 114
- CAT 5
- GEN $53.0K
- TOP1 72.4%
- PY 2024
Volume peers
Nearest volume peer: ImpactOrtho, Inc. ($52.7K)
On Target Laboratories, Inc sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for On Target Laboratories, Inc
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For On Target Laboratories, Inc that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
"Education" leads the 5-category general-payment breakdown below at $25.0K (47.2% of General Payments, 7 transactions) - see our methodology for how research and ownership payments are reported separately.
General Payment Breakdown by Type
"Education" leads On Target Laboratories, Inc's 5-category general-payment breakdown at $25.0K, 47.2% of the reported total.
On Target Laboratories, Inc reports 5 general-payment categories - the top three are Education (47.2%), Consulting Fee (27.4%), and Food and Beverage (15.9%). The remaining 2 categories make up 9.6% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How On Target Laboratories, Inc divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Education | $25.0K | 7 | 47.2% |
| Consulting Fee | $14.5K | 3 | 27.4% |
| Food and Beverage | $8.4K | 101 | 15.9% |
| Travel and Lodging | $3.6K | 2 | 6.7% |
| Compensation for Services Other Than Consulting | $1.5K | 1 | 2.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $46,500.01 (87.8%) of $52,963.40 in this company's General Payments records across 71 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for On Target Laboratories, Inc
The five named recipients with the highest reported General Payments from this company
- 1
Nicholas Baker
$38,363.96 across 19 reported transactions
- 2
Federico Steiner
$5,298.03 across 5 reported transactions
- 3
Michael Ebright
$2,230.22 across 3 reported transactions
- 4
David Hall
$310.85 across 3 reported transactions
- 5
Alberto De Hoyos
$296.95 across 1 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
On Target Laboratories, Inc ranks #1336 of 1,925 by total payments (bottom 31% by spend) but is notably more concentrated than that alone would suggest -- #308 of 1,838 by HHI (top 17% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Theragenics Corporation : $135.5K total payments, HHI 5468
- Orpyx Medical Technologies Inc. : $5.8K total payments, HHI 5463
- OraBio, Inc. : $98.2K total payments, HHI 5429
- Vascular Technology, Inc. : $943.2K total payments, HHI 5399
- BeiGene Switzerland GmbH : $140.6K total payments, HHI 5399
- Forma Medical : $61.1K total payments, HHI 5390
- On Target Laboratories, Inc (this company) : $53.0K total payments, HHI 5369
- Teikoku Pharma USA, Inc. : $21.4K total payments, HHI 5368
- Avantec Vascular Corporation : $17.9K total payments, HHI 5355
- Nico Corporation : $105.7K total payments, HHI 5350
- Gebauer Company : $15.3K total payments, HHI 5350
- Affordable Pharmaceuticals, LLC : $766.7K total payments, HHI 5325
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as On Target Laboratories, Inc's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about On Target Laboratories, Inc.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with On Target Laboratories, Inc.
Showing 6 of 1,924 companies with CMS-reported payment data.
Sioux Surgical Inc
$53.3K 390 recipients
Compare payment profiles
Seagen Inc.
$52.4K 561 recipients
Compare payment profiles
Roche Diabetes Care GmbH
$52.4K 31 recipients
Compare payment profiles
Infinity BiologiX LLC
$52.4K 9 recipients
Compare payment profiles
Pierre Fabre Pharmaceuticals, Inc.
$53.6K 165 recipients
Compare payment profiles
Put this to use
On Target Laboratories, Inc ranks #1336 of 1,925 by all-tracks total payments, led by "Education".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Education" spend across every manufacturer, not just On Target Laboratories, Inc. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.